Sputum IL-6 concentrations in severe asthma and its relationship with FEV1

Morjaria, J .B., Babu, K .S., Vijayanand, P., Chauhan, A.J., Davies, D.E. and Holgate, S. (2010) Sputum IL-6 concentrations in severe asthma and its relationship with FEV1 Thorax, 66 (6), p. 537. (doi:10.1136/thx.2010.136523). (PMID:20880874).


Full text not available from this repository.


As asthma becomes more severe it adopts additional characteristics including corticosteroid refractoriness and a neutrophil-predominant inflammatory response implicating Th1 or Th17 responses involving cytokines such as tumour necrosis factor ?, interleukin (IL)-6 and IL-8. We have examined the role of IL-6 and IL-8 in severe asthma. Subjects with severe asthma (GINA stage IV) who were exacerbation-free for ?4 weeks with a forced expiratory volume in 1 s (FEV 1) >30% but <80% predicted were studied from the baseline parameters of a clinical trial. 1 Cell counts and cytokines were measured in induced sputum (see online supplement for Methods).

Eighteen subjects (9M, 9F) with severe asthma (mean±SD age 43.4±11.4 years (1SD), FEV 1 59±14% predicted) were studied (see table 1 in online appendix). The median (IQR) levels of sputum IL-8, IL-6, neutrophils (%), macrophages (%) and eosinophils (%) were 1853.8 pg/ml (1376.8–2537.7), 70.0 pg/ml (28.55–127.5), 32.5% (24.1–42.6), 46.8% (39.8–54.8) and 4.4% (3.2–9.4), respectively. We observed significant negative correlations between FEV 1 …

Item Type: Article
Digital Object Identifier (DOI): doi:10.1136/thx.2010.136523
ISSNs: 0040-6376 (print)

ePrint ID: 187377
Date :
Date Event
29 September 2010Accepted/In Press
June 2011Published
Date Deposited: 17 May 2011 09:23
Last Modified: 18 Apr 2017 02:09
Further Information:Google Scholar
URI: http://eprints.soton.ac.uk/id/eprint/187377

Actions (login required)

View Item View Item